Literature DB >> 1676688

Advances in immunotoxins.

T N Oeltmann1, A E Frankel.   

Abstract

The field of immunotoxins is continuing to grow, as shown by the increase in attendance (175 vs. 145) and abstracts (110 vs. 60) at the symposium. Advances in the molecular biology of the toxins and clinical applications were notable at this meeting. The next 2 years should see better definition of the mechanism of action of peptide toxins as well as improvements in the design of targeted toxins for potential therapy of a wide variety of human diseases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1676688     DOI: 10.1096/fasebj.5.10.1676688

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  2 in total

1.  Mice are actively immunized after passive monoclonal antibody prophylaxis and ricin toxin challenge.

Authors:  P V Lemley; D C Wright
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

2.  Meta-analysis of nanoparticulate paclitaxel delivery system pharmacokinetics and model prediction of associated neutropenia.

Authors:  Sihem Ait-Oudhia; Robert M Straubinger; Donald E Mager
Journal:  Pharm Res       Date:  2012-05-17       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.